Medicine Supply Notification: Glucagon (GlucaGen®) 1mg powder for injection kit
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Glucagon (GlucaGen®) 1mg powder for injection kit .
MSN/2023/051
Tier 2 – medium impact
Date of issue 18th December 2023
- There are two licensed glucagon preparations: GlucaGen® (1mg powder for injection kit) and Ogluo® (0.5mg and 1mg pre-filled auto-injector pens)
- There will be intermittent supply of GlucaGen® 1mg powder for injection kit until the end of March 2024.
- Supply of GlucaGen® 1mg powder for injection kit allows demand to be met in primary care.
- Ogluo® 0.5mg and 1mg pre-filled auto-injector pens are available (from Alliance) and can be used for the treatment of severe hypoglycaemic episodes; however, they are not suitable for treatment of beta blocker or other drug overdoses.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
